HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Iopamidol and Conray 60: comparison in superselective angiography.

Abstract
Iopamidol (280 mgI/ml) was compared with Conray 60 (iothalmate meglumine, 282 mgI/ml) during selective and superselective cerebral arteriography. Twelve patients were examined, and a total of 51 selective injections were compared. Iopamidol produced significantly less pain and burning than Conray 60 and caused no patient motion.
AuthorsS M Schonfeld, R S Pinto, A R Schonfeld, A Berenstein, M Manuell, I I Kricheff
JournalRadiology (Radiology) Vol. 152 Issue 3 Pg. 809-11 (Sep 1984) ISSN: 0033-8419 [Print] United States
PMID6379748 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Iothalamic Acid
  • Iopamidol
  • Iothalamate Meglumine
Topics
  • Adult
  • Aged
  • Cerebral Angiography (methods)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Facial Neoplasms (diagnostic imaging)
  • Female
  • Hemangioma (diagnostic imaging)
  • Humans
  • Intracranial Arteriovenous Malformations (diagnostic imaging)
  • Iopamidol
  • Iothalamate Meglumine (adverse effects)
  • Iothalamic Acid (adverse effects, analogs & derivatives)
  • Male
  • Meningeal Neoplasms (diagnostic imaging)
  • Meningioma (diagnostic imaging)
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: